About: The bigger the better? ... or what we know and what we still need to learn about anthracycline dose per course, dose density and cumulative dose in the treatment of breast cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The bigger the better? ... or what we know and what we still need to learn about anthracycline dose per course, dose density and cumulative dose in the treatment of breast cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 1997 (uk) article scientifique publié en 1997 (fr) im Dezember 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 1997 (ast) scientific article published on 01 December 1997 (en) գիտական հոդված հրատարակված 1997 թվականի դեկտեմբերի 1-ին (hy)
publication date	wds:Q74296304-AEF825AF-6FE6-442E-AA30-A59E756C18DD
publication date	1997-12-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q74296304-21FCD194-926C-4D63-98DA-B9DE6F5413FA wds:Q74296304-247E4EE3-50FB-44B1-ABD2-6114F151E51D wds:Q74296304-3F600A79-49AA-43DD-A766-6CDBDB2F1E40 wds:Q74296304-3FCC958C-240B-4BDE-9D80-B005B64A0ABC wds:Q74296304-48E5BF1D-9088-4181-8FF0-9ADF2A32EB81 wds:Q74296304-568ED2B6-4309-4F57-BEEE-BCBDB0E63895 wds:Q74296304-612D6E19-8ED2-4141-9FBB-E0E677FC3C95 wds:Q74296304-6888FD74-2B9F-453D-A494-35CFBF781CFB wds:Q74296304-69CBD950-0894-4E74-9226-6C3773211CE1 wds:Q74296304-7CACCEDC-D747-4B38-AE12-F4024AB02CFB wds:Q74296304-AB9AEBC9-D937-40FF-AC07-B19BB95B287F wds:Q74296304-ACDE6562-4BF0-48D4-8BFD-26F1CAB960CE wds:Q74296304-CDEA716D-77F9-48DB-964E-3DC674C5A301 wds:Q74296304-F41998CB-70BB-4057-9609-C03FAC9BB743 wds:Q74296304-FD525E4D-4854-4AFD-8FC1-497B5C801E88
cites work	Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer The Duke AFM Program. Intensive induction chemotherapy for metastatic breast cancer Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer The importance of dose intensity in chemotherapy of metastatic breast cancer Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimens. Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group. High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study Dose-response relationship of epirubicin-based first-line chemotherapy for advanced breast cancer: a prospective randomized trial Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: the results of a randomized trial More is better Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer. The Epirubicin High Dose (HEPI 010) Study Group
author name string	wds:Q74296304-D36CF3C3-C82D-4CD6-A301-714CB6053BB7
author name string	M J Piccart
rdfs:label	The bigger the better? ... or what we know and what we still need to learn about anthracycline dose per course, dose density and cumulative dose in the treatment of breast cancer (en) The bigger the better? ... or what we know and what we still need to learn about anthracycline dose per course, dose density and cumulative dose in the treatment of breast cancer (nl)
skos:prefLabel	The bigger the better? ... or what we know and what we still need to learn about anthracycline dose per course, dose density and cumulative dose in the treatment of breast cancer (en) The bigger the better? ... or what we know and what we still need to learn about anthracycline dose per course, dose density and cumulative dose in the treatment of breast cancer (nl)
name	The bigger the better? ... or what we know and what we still need to learn about anthracycline dose per course, dose density and cumulative dose in the treatment of breast cancer (en) The bigger the better? ... or what we know and what we still need to learn about anthracycline dose per course, dose density and cumulative dose in the treatment of breast cancer (nl)
author	wds:Q74296304-962F27FA-CD60-43AF-8B75-D898ADB5974B
author	Laura Biganzoli
title	wds:Q74296304-BFBD6495-6661-4720-B160-0CC710B38921
title	The bigger the better? ... or what we know and what we still need to learn about anthracycline dose per course, dose density and cumulative dose in the treatment of breast cancer (en)
page(s)	wds:Q74296304-F5FA44B6-7960-41D7-A1DC-0D8D83C52895
page(s)	1177-1182
instance of	wds:Q74296304-9365b7c9-6c73-4e6f-89f3-e24be5129de1 wds:Q74296304-F1A320EC-05EB-44D1-86B9-35A8FE14C148 wds:Q74296304-d17b2140-19d9-4155-9dd4-a715dbe0dd0f
instance of	editorial review article scholarly article
PubMed ID	wds:Q74296304-57D84102-DD26-4842-891B-FCECE186658B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9496381
PubMed ID	9496381
published in	wds:Q74296304-A709CF5F-8B05-4633-A8EE-DEE0ADF4F067
published in	Annals of Oncology
issue	wds:Q74296304-B8AA50E8-41D3-4F88-8934-C25E23B91A63
volume	wds:Q74296304-996CF345-E47C-4F6C-BFF2-6708BD1BCBA9
issue	12
volume	8
DOI	wds:Q74296304-374C8B1C-2E74-413D-8F0D-BDDB57CE2A96
DOI	http://dx.doi.org/10.1023/A:1008295432012
DOI	10.1023/A:1008295432012
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74296304
is cites work of	Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials Is òne cycle every three or four weeks' obsolete? A critical review of dose-dense chemotherapy in solid neoplasms Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs. Neutropenia and relative dose intensity on adjuvant FOLFOX chemotherapy are not associated with survival for resected colon cancer The impact of chemotherapy dose density and dose intensity on breast cancer outcome: what have we learned? Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer More on dose-intensity of anthracyclines in breast cancer A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01) Randomized phase II study of FEC day 1 + 8 and FEC day 1 in patients with advanced breast cancer
is cites work of	wds:Q33753705-2AD2079D-AA9A-411C-A4E6-C7097E1216BC wds:Q38228214-C7F33C39-ED05-4E31-88D8-C2B0C083ED0C wds:Q74687132-71D460AE-DB1E-4FB2-8186-D2D958E1A1D2 wds:Q33900916-63D8C009-F5C2-49F7-8F01-90D59419DB3F wds:Q28344321-5F65C50E-3A52-436C-AE4B-D62FBD59EA84 wds:Q33332712-5C46E408-9BAA-4237-A7D1-F0DCC2D6626D wds:Q74604118-1F849B50-0537-464C-AB08-9D874558C50D wds:Q34696189-556C6C3E-DBF6-4E16-9D3B-AA87BD3D3A46 wds:Q33889873-953CEF2A-563B-49A1-BEAF-CD686D45C8AD

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software